PSYCH
PSYCH
  • Видео 73
  • Просмотров 16 189
PSYCH Symposium: Shifting Perceptions - in conversation with Professor Robin Carhart-Harris
A fully regulated psychedelic medicine industry has arguably never been closer. The ecosystem is already in place, waiting for the legislatorial dial to move. If widespread regulation arrived tomorrow, what would happen next? From worldwide mental health through to perhaps even political discourse, how would various sections of society be affected; and are they ready for it?
At PSYCH symposium, this one-on-one interview between journalist Kate Spicer and the pioneering Prof. Robin Carhart-Harris explored the possible realities of psychedelics as part of our societal fabric.
Просмотров: 1 498

Видео

PSYCH Symposium: Solutions for police are solutions for society
Просмотров 82Год назад
There is a growing political crisis with falling public confidence in police, in the UK, the EU, and around the world. This is an opportunity to shift public and political perceptions as to the solutions, as the crisis in policing can not be solved without solving the mental health crisis in policing. The secret to preparing and growing a market is identifying the need. Solutions follow. With a...
PSYCH Symposium: Clearing a Path for Treatment
Просмотров 149Год назад
With both an increase in psychedelic clinical trials and adoption of new regulations allowing access to psychedelic therapies, the need for trained facilitators and therapists who can provide these services becomes vital. Drawing on the recent developments in policy, this PSYCH Symposium panel discussed the urgency of companies needing to train therapists before this becomes a roadblock for pat...
PSYCH Symposium: Atlantic Psychedelics - From Discovery to Delivery
Просмотров 102Год назад
PSYCH Symposium's Atlantic Psychedelic panel explored the complexities that psychedelic compounds bring to drug development and speak of their experience on both sides of the Atlantic (US, Canada and UK) and within the Commonwealth (Australia). Featuring: George McBride, Chief Commercial Officer, Clerkenwell Health. Clare Knight, Senior Clinical Trials Manager, Clerkenwell Health. Nicholas Kady...
PSYCH Symposium: Neuroimaging and Psychedelics
Просмотров 125Год назад
A panel of experts explored the key neuroimaging findings to date, and how neuroimaging technologies can support and accelerate both our knowledge of psychedelic brain mechanisms, and the clinical development of associated therapies. Featuring: Dr. Chris Timmermann, Psychedelic Research Clinician, Imperial College London. Beata Godlewska, Clinical Researcher, Department of Psychology, Oxford Un...
PSYCH Symposium: The Future of Psychedelic Medicine in the EU
Просмотров 163Год назад
There is a growing belief that research around the potential of psychedelics is finally making key policymakers within the European Parliament stand up and take notice. With organisations like PAREA now facilitating meaningful conversations which could lead to a shift in perception, how could the EU take a central role in driving psychedelic healthcare to become a reality across Europe? PSYCH S...
PSYCH Symposium: Reassessing the Psychedelic Space
Просмотров 682Год назад
In the psychedelic sector a period of unabashed exuberance has given way to a sobering couple of years, with company valuations and investment tumbling amidst broader economic turmoil. Despite this challenging financial backdrop, a first-in-class psychedelic-assisted therapy could be approved as early as next year and public interest in these substances shows no sign of slowing. In this firesid...
PSYCH Symposium: Understanding institutional investors’ interest in psychedelics
Просмотров 100Год назад
Institutional investors are interested in the psychedelic medicine sector but they are not investing. So, what is holding them back and what would encourage them to take an equity position? FTI Consulting issued a survey to institutional investors in the UK and US to understand their level of interest in the sector, how they expect the sector to perform in the coming years and what are the cata...
PSYCH Symposium: Access to Psychedelic Medicines
Просмотров 166Год назад
PSYCH Symposium 2023 saw a panel of experts discuss the reality of the new psychedelic market and the complicated framework healthcare professionals and policymakers need to work within, whilst also looking at what we can learn from recent developments in Australia. Featuring: Dr. Farrah Jarral, Writer, Broadcaster and GP. Dr. Guy Goodwin, Chief Medical Officer, COMPASS Pathways. Charlotte Nich...
PSYCH Symposium: Ketamine assisted therapy to treat addiction
Просмотров 227Год назад
Professor Celia Morgan speaks about Awakn Life Sciences' programmes of research investigating ketamine-assisted therapy across AUD and behavioural addictions, which together have aimed to develop an efficient treatment that will be easy to implement in existing healthcare systems.
PSYCH Symposium: Challenges in Psychedelic Drug Development
Просмотров 95Год назад
Challenges in Psychedelic Drug Development: Psychedelics induce non-ordinary states of consciousness, which creates unique challenges in the design and conduct of research studies. This panel of experts explored some of the key challenges that are critical to good clinical development in this space. Featuring: Dr. Amir Inamdar, Chief Medical Officer, Cybin Inc. Dr. Catherine Schuster-Bruce, Jou...
PSYCH Symposium: Treating eating disorders
Просмотров 129Год назад
Building patterns and reducing prevalence: PSYCH Symposium explores how psychedelics can create potential mechanisms for the brain to cope with the key triggers of eating disorders. Featuring: Rivki Stern, CEO, Shortwave Pharma. Professor Rebecca Park, Associate Professor & Honorary, Consultant Psychiatrist, Speaker, Oxford University. Yoel Golbert, Clinical Psychologist and Psychedelic Researc...
PSYCH Symposium: London 2023
Просмотров 49Год назад
PSYCH Symposium: London 2023
PSYCH Symposium: Shortwave Opening Remarks
Просмотров 42Год назад
PSYCH Symposium: Shortwave Opening Remarks
PSYCH Symposium | Dr Anne Schlag
Просмотров 33Год назад
Join experts and thought leaders at PSYCH Symposium on 6 July at the British Museum.
PSYCH Symposium: London 2023
Просмотров 137Год назад
PSYCH Symposium: London 2023
PSYCH Symposium | Amanda Feilding
Просмотров 90Год назад
PSYCH Symposium | Amanda Feilding
Measuring Ketamine’s Efficacy with Neuroimaging | PSYCH Symposium: London 2022
Просмотров 2242 года назад
Measuring Ketamine’s Efficacy with Neuroimaging | PSYCH Symposium: London 2022
PSYCH Webinar - COMPASS Pathways
Просмотров 4022 года назад
PSYCH Webinar - COMPASS Pathways
How Can We Promote Public Education and Patient Accessibility? | PSYCH Symposium: London 2022
Просмотров 1192 года назад
How Can We Promote Public Education and Patient Accessibility? | PSYCH Symposium: London 2022
How Can Investors Benefit from a Bear Market? | Christian Angermayer | PSYCH Symposium: London 2022
Просмотров 2612 года назад
How Can Investors Benefit from a Bear Market? | Christian Angermayer | PSYCH Symposium: London 2022
When will MDMA-assisted therapy be available in Europe? | Rick Doblin | PSYCH Symposium: London 2022
Просмотров 3752 года назад
When will MDMA-assisted therapy be available in Europe? | Rick Doblin | PSYCH Symposium: London 2022
The Psychedelic Renaissance: A Family Affair | PSYCH Symposium: London 2022
Просмотров 4232 года назад
The Psychedelic Renaissance: A Family Affair | PSYCH Symposium: London 2022
A Surge in Synthetic Psychedelic Medicines | PSYCH Symposium: London 2022
Просмотров 2892 года назад
A Surge in Synthetic Psychedelic Medicines | PSYCH Symposium: London 2022
Accessing Psilocybin in the UK | Crispin Blunt MP | PSYCH Symposium: London 2022
Просмотров 3192 года назад
Accessing Psilocybin in the UK | Crispin Blunt MP | PSYCH Symposium: London 2022
Psychedelic Healthcare Without Hallucinations | Professor Bryan Roth | PSYCH Symposium: London 2022
Просмотров 3402 года назад
Psychedelic Healthcare Without Hallucinations | Professor Bryan Roth | PSYCH Symposium: London 2022
How Integral is Patient Integration? | PSYCH Symposium: London 2022
Просмотров 4312 года назад
How Integral is Patient Integration? | PSYCH Symposium: London 2022
The Psychedelic Medicines of Tomorrow | PSYCH Symposium: London 2022
Просмотров 2372 года назад
The Psychedelic Medicines of Tomorrow | PSYCH Symposium: London 2022
Fighting PTSD with Psychedelic Healthcare | PSYCH Symposium: London 2022
Просмотров 1052 года назад
Fighting PTSD with Psychedelic Healthcare | PSYCH Symposium: London 2022
Rumination and Escaping Depression | Professor David Nutt | PSYCH Symposium: London 2022
Просмотров 1,6 тыс.2 года назад
Rumination and Escaping Depression | Professor David Nutt | PSYCH Symposium: London 2022

Комментарии

  • @BushyHairedStranger
    @BushyHairedStranger 7 месяцев назад

    Thomas M. Ling M.A., M.D., M.R.C.P at Marlborough Day Hospital, London & John Buckman M.R.C.S., L.R.C.P., D.P.M. Marlborough Day Hospital conducted excellent research on LSD & Anxiety 60 years ago. Not sure why these younger researchers overlook the literature and keep stumbling over covered ground(?) this research was heavily covered decades ago! LSD works incredibly well for Anxiety, we’ve known this for 60 years!

  • @loushark6722
    @loushark6722 11 месяцев назад

    Nematodes are boring? Cox is a rockstar scientist? You wouldn't say this interviewer has her finger on the pulse exactly. 😂

  • @stephensnowdon5633
    @stephensnowdon5633 Год назад

    I think sharing the experience from your psychiatric nurse colleague was a really good way of dropping in a very sensitive and poignant topic. Awesome as always keep up the good work. 👍

  • @helvetiaresearch9973
    @helvetiaresearch9973 Год назад

    Professor Robin Carhart-Harris is the best.

  • @perryn2930
    @perryn2930 Год назад

    'Promo SM' 😪

  • @Gatchaman__zero
    @Gatchaman__zero Год назад

    Pharmala Biotech does not manufacture anything, so that was a lie straight off the bat from Nicholas Kadysh, Founding CEO & President, PharmAla Biotech. Pharmala is just a MDMA middleman. "PharmAla is a research entity and does not physically possess any Controlled Substances. All work is completed by duly licensed laboratories." Taken from the bottom of the Pharmala website. Listen to Nick say Pharmala does not manufacture MDMA 16 May 2023 Psychedelics Today podcast PT410 - Nick Kadysh - Manufacturing MDMA and Why Creating MDMA Analogs Is So Important

  • @thedandelionranger
    @thedandelionranger Год назад

    The elves are happy with you fellas.

  • @bacciuelmagnifico5943
    @bacciuelmagnifico5943 2 года назад

    Also Leute ich unterstütze euch schon als Aktionär soweit es meine Möglichkeiten zulassen aber gibt bitte gas. Ich habe schon 5 Bekannten die Selbstmord begangen haben. Das wird langsam zu den häufigsten Todesursachen. Ich glaube an Euch!

  • @MrPencilcelebs
    @MrPencilcelebs 2 года назад

    If a surfer sitting on his surfboard doesn’t paddle like mad and get to his feet, the wave passes right on by. Yes, I realize we’re at that stage of counterbalancing a decade plus of glowing idealism about psychedelic experiences, but I hope we don’t devalue what, all things considered, is still as promising an addition to the western therapist’s tool kit as anything since the birth of therapy itself.

  • @a-rye
    @a-rye 2 года назад

    Having lost my father to alcoholism and ultimately suicide, I want to thank you all for your work in mental health! I hope more places take to decriminalizing and legalizing these wonderful medications.

  • @RKOPanda7104
    @RKOPanda7104 2 года назад

    Amazing work from wise humans!! What a shame such natural medicines have been banned for personal use. I pray this changes.

  • @asemic
    @asemic 2 года назад

    Rick and other non-profits: please review law 13 in the book The 48 Laws of Power. This is not an endorsement of the book.

  • @asemic
    @asemic 2 года назад

    I hope taxes involved in this don't go towards persecuting traditional use. I don't mean to villainize anyone, but we must consider market forces long term--and if the rumor of COMPASS chasing things like patenting the use of couches in psychedelic therapy is true, we may have to consider it short-term as well. Mush Love

  • @SouthAfricanCannabisExtraction
    @SouthAfricanCannabisExtraction 2 года назад

    Really fantastic to see the channel has been so active over the last month, really enjoying the interviews and content! Keep up the amazing work.

  • @ivankeliimov6795
    @ivankeliimov6795 2 года назад

    ruclips.net/video/T2rMlc_0Cw4/видео.html

  • @alexcalderon5461
    @alexcalderon5461 2 года назад

    $MNMD 💪🏻

  • @thesweatshed5230
    @thesweatshed5230 2 года назад

    Hello!, keep up the work. You will enjoy this channel 👉 #drjohnaking. I find him encouraging and insightful.

  • @trc3675
    @trc3675 2 года назад

    Rip off company! I made a significant purchase two months ago and never received anything! I sent emails via Gwella's website to inquire about this, but nobody ever responded back to me.

  • @honkystonk1142
    @honkystonk1142 2 года назад

    These viddys are really good ya gonna keep it up? 🤔

  • @CognitiveInsurance
    @CognitiveInsurance 2 года назад

    giimme

  • @neilrigger
    @neilrigger 3 года назад

    I like the stock and I’m not a cat.

  • @vardanyanser
    @vardanyanser 3 года назад

    Rick Doblin is a legend ✊

  • @ericquintanar1
    @ericquintanar1 3 года назад

    Glad to be a small share hold I plan on buying more and holding. Keep up the good work y'all

  • @thereporter3690
    @thereporter3690 3 года назад

    High risk , big rewards for investors

  • @BushyHairedStranger
    @BushyHairedStranger 3 года назад

    …….another terrible company thats wants to use Psilocybin DERIVATIVES as a capital builder for Plutocratic Oligarch…f-you.

  • @growingwithgod8847
    @growingwithgod8847 3 года назад

    This is a great company, doing great things!

  • @Jake-py9bx
    @Jake-py9bx 3 года назад

    Psymposia is going to have a field day with this one

    • @BushyHairedStranger
      @BushyHairedStranger 3 года назад

      You mean have a field day with Atai buying off Doblin and owning Maps?

    • @Jake-py9bx
      @Jake-py9bx 3 года назад

      @@BushyHairedStranger Yes and Angermayer's characterisation of psychedelics as religious drugs

  • @adingoatemyxrp1704
    @adingoatemyxrp1704 3 года назад

    Patent trolling psychedelics and fighting against their legalization might be wise from a financial standpoint for Christian's company, but it is unwise if his intention is to democratize availability.

  • @michaeltripp5519
    @michaeltripp5519 3 года назад

    Great segment!

  • @Victoria-bk2vp
    @Victoria-bk2vp 3 года назад

    🙌🏼🙌🏼

  • @etherealliz1
    @etherealliz1 3 года назад

    Invaluable

  • @fettmund9077
    @fettmund9077 3 года назад

    Great info, thank you.